Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma

被引:0
作者
Arnold Bolomsky
Dirk Hose
Martin Schreder
Anja Seckinger
Susanne Lipp
Bernard Klein
Daniel Heintel
Heinz Ludwig
Niklas Zojer
机构
[1] Department of Internal Medicine I,Wilhelminen Cancer Research Institute
[2] Wilhelminenspital,Medizinische Klinik V
[3] Universitaetsklinikum Heidelberg,INSERM U1040, Institute for Research in Biotherapy
[4] CHU Montpellier,undefined
[5] Hospital St Eloi,undefined
来源
Journal of Hematology & Oncology | / 8卷
关键词
Multiple myeloma; IGFBP7; Microenvironment; Myeloma bone disease; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 482 条
[1]  
Palumbo A(2011)Multiple myeloma N Engl J Med 364 1046-60
[2]  
Anderson KC(2010)Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays BMC Cancer 10 198-90
[3]  
Mahtouk K(2011)Osteoclast-gene expression profiling reveals osteoclast derived CCR2 chemokines promoting myeloma cell migration Blood 117 1280-88
[4]  
Moreaux J(2007)Bone marrow mesenchymal stem cells are abnormal in multiple myeloma Leukemia 21 1079-26
[5]  
Hose D(1989)Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6 Blood 73 517-26
[6]  
Rème T(2009)The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor Blood 113 4614-50
[7]  
Meissner T(2010)Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation Leukemia 24 1940-6
[8]  
Jourdan M(2001)Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression Proc Natl Acad Sci U S A 98 11581-94
[9]  
Rossi JF(2003)The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma N Engl J Med 349 2483-9
[10]  
Pals ST(2010)Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease Proc Natl Acad Sci U S A 107 5124-501